Landaas & CO Abbott Laboratories Transaction History

Landaas & CO

$357 Million
Q3 2024

A detailed history of Landaas & CO transactions in Abbott Laboratories stock. As of the latest transaction made, Landaas & CO holds 3,598 shares of ABT stock, worth $404,091. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,598

Previous 3,598 -0.0%

Holding current value

$404,091

Previous $373,000 9.92%

% of portfolio

0.11%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $133,467 - $148,983	-1,325 Reduced 26.91%	3,598 $373,000
Q1 2024 May 09, 2024	SELL	$109.52 - $120.96 $98,568 - $108,864	-900 Reduced 15.46%	4,923 $559,000
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $59,435 - $72,753	659 Added 12.76%	5,823 $640,000
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $17,132 - $19,089	-170 Reduced 3.19%	5,164 $562,000
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $19,372 - $22,802	-200 Reduced 3.61%	5,334 $540,000
Q4 2022 Feb 15, 2023	BUY	$95.06 - $111.52 $9,506 - $11,152	100 Added 1.84%	5,534 $607,000
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $3,062 - $3,701	-30 Reduced 0.55%	5,434 $590,000
Q2 2021 Aug 17, 2021	SELL	$105.79 - $124.53 $10,579 - $12,453	-100 Reduced 1.8%	5,464 $633,000
Q1 2021 May 11, 2021	BUY	$108.84 - $128.23 $155,097 - $182,727	1,425 Added 34.43%	5,564 $667,000
Q3 2020 Nov 06, 2020	SELL	$91.64 - $111.29 $563,769 - $684,656	-6,152 Reduced 59.78%	4,139 $450,000
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $6,956 - $7,542	-85 Reduced 0.82%	10,291 $861,000
Q2 2019 Jul 29, 2019	SELL	$72.88 - $85.0 $14,576 - $17,000	-200 Reduced 1.89%	10,376 $873,000
Q1 2019 Apr 19, 2019	BUY	$66.22 - $80.06 $644,386 - $779,063	9,731 Added 1151.6%	10,576 $845,000
Q1 2019 Apr 18, 2019	SELL	$66.22 - $80.06 $644,320 - $778,983	-9,730 Reduced 92.01%	845 $845,000
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $6,424 - $7,278	-98 Reduced 0.92%	10,575 $765,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $60 - $73	1 Added 0.01%	10,673 $783,000
Q2 2018 Aug 07, 2018	BUY	$57.57 - $63.54 $115 - $127	2 Added 0.02%	10,672 $651,000
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $5,739 - $6,489	102 Added 0.97%	10,670 $639,000
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $235,762 - $252,408	-4,392 Reduced 29.36%	10,568 $603,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $718,977 - $802,454	14,960	14,960 $798,000

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

News

Stay updated on Landaas & CO with notifications on news.

Account